8-K

                                 UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

                                October 12, 2005
                                ----------------
                                 Date of Report
                        (Date of Earliest Event Reported)

                        IMAGING DIAGNOSTIC SYSTEMS, INC.
             ------------------------------------------------------
             (Exact name of registrant as specified in its charter)

         Florida                       0-26028                 22-2671269
         -------                       -------                 ----------

(State or Other Jurisdiction of (Commission File Number)   (I.R.S. Employer
 Incorporation or Organization)                           Identification Number)

                               6531 NW 18TH COURT
                              PLANTATION, FL 33313
               --------------------------------------------------
                    (Address of principal executive offices)


                                 (954) 581-9800
                    -----------------------------------------
                         (Registrant's telephone number)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act
     (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
     (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
    Act.  (17 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
    Act.  (17 240.13e-4(c))





ITEM 2.02   RESULTS OF OPERATIONS AND FINANCIAL CONDITION.

ITEM 7.01   REGULATION FD DISCLOSURE.

Imaging Diagnostic Systems, Inc. (the "Company") hereby furnishes a press
release issued on October 12, 2005 and attached hereto as Exhibit 99.1 and
incorporated herein by reference disclosing material non-public information
regarding the Company's sales expected to be reported for the quarter ended
September 30, 2005.

The information, including the exhibit, the Company furnishes in this report on
Form 8-K is not deemed "filed" for purposes of section 18 of the Securities
Exchange Act of 1934, as amended, or otherwise subject to the liabilities of
that section. Registration statements or other documents filed with the
Securities and Exchange Commission shall not incorporate this information by
reference, except as otherwise expressly stated in such filing.

ITEM 9.01   FINANCIAL STATEMENTS AND EXHIBITS

             (c) Exhibits

Exhibit No.                Description of Exhibits

99.1    Press release dated October 12, 2005, entitled, "Imaging Diagnostic
        Systems reports strong first quarter revenue"


SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                IMAGING DIAGNOSTIC SYSTEMS, INC.

Dated October 12, 2005


                                   /s/ Allan L. Schwartz
                                   ---------------------
                                   By: Allan L. Schwartz
                                   Executive Vice President
                                   Chief Financial Officer

EX-99

                                  EXHIBIT 99.1

         IMAGING DIAGNOSTIC SYSTEMS REPORTS STRONG FIRST QUARTER REVENUE

                        Record Five CTLM(R) Systems Sold


Fort Lauderdale, Florida, October 12, 2005--Imaging Diagnostic Systems, Inc.,
(OTCBB: IMDS) reported today that a record five CT Laser Mammography (CTLM(R))
systems were sold in the quarter ending September 30, 2005.

In the quarter ending September 30, 2005, IDSI is expected to report net sales
of $671,750, up from the $374,952 reported for the entire previous fiscal year
ending June 30, 2005.

"Our first fiscal quarter was a clear endorsement of the effectiveness of our
global commercialization program and growing market acceptance of laser breast
scanning. Four of the five sales had been announced via press releases; details
of the fifth will soon be released. We are gaining traction in several key
geographic areas as our distributors and clinical partner sites gain experience
with this new technology. It is an exciting time," stated Tim Hansen, IDSI Chief
Executive Officer.

The CTLM(R) system is the first patented breast imaging system that utilizes
state-of the-art laser technology and patented algorithms to create 3-D cross-
sectional images of the breast. It is a non-invasive, painless examination that
does not expose the patient to radiation or require breast compression. Imaging
Diagnostic Systems has received CE Marking, CMDCAS (Canada), Canadian License,
China SFDA approval, UL listing, ISO 9001:2000-13488 certification and FDA
export certification for its CT Laser Breast Imaging system. The Company is
seeking PreMarket Approval (PMA) from the Food and Drug Administration (FDA) for
its CTLM(R) system to be used as an adjunct to mammography.

Please visit Imaging Diagnostic Systems' website at: www.imds.com for additional
information.


In conjunction with the provisions of the Safe Harbor section of the Private
Securities Litigation Reform Act of 1995, this news release may contain
forward-looking statements pertaining to future anticipated projected plans,
performances and developments, as well as other statements relating to future
operations. All such forward-looking statements are necessarily only estimates
of future results and there can be no assurance that actual results will not
materially differ from expectation. Further information on potential factors
that could affect Imaging Diagnostic Systems, Inc., is included in the Company's
filing with the Securities Exchange Commission.


Investor Relations:
Rick Lutz
404-261-1196
lcgroup@mindspring.com
- ----------------------